AstraZeneca (AZN)

  • A brief financial summary of AstraZeneca as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Select Exchange

Symbol Exchange Currency
AZN London GBP Real-time 3LAZ London GBP Real-time 3SAZ London GBP Real-time AZNl BATS Europe GBP Delayed AZNs BATS Europe SEK Delayed AZN NASDAQ USD Real-time AZNCF OTC Markets USD Delayed AZNN Mexico MXN Delayed AZN Stockholm SEK Real-time AZN Frankfurt EUR Delayed AZN TradeGate EUR Delayed AZN Xetra EUR Delayed AZNPy Frankfurt EUR Delayed AZN Buenos Aires ARS Delayed
123.40 -0.75 (-0.60%)
Closed EUR Disclaimer

AZN Financial Summary

AstraZeneca PLC reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was USD 11,207 million compared to USD 12,011 million a year ago. Net income was USD 901 million compared to net loss of USD 347 million a year ago. Basic earnings per share from continuing operations was USD 0.58 compared to basic loss per share from continuing operations of USD 0.22 a year ago. Diluted earnings per share from continuing operations was USD 0.58 compared to diluted loss per share from continuing operations of USD 0.22 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
AZN Income Statement
AZN
Gross margin TTM 80.57%
Operating margin TTM 20.21%
Net Profit margin TTM 7.41%
Return on Investment TTM 10.18%
Total Revenue
Net Income
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Revenue 11,207 10,982 10,771 11,390
Gross Profit 8,737 8,941 8,942 9,111
Operating Income 1,668 2,282 2,021 2,808
Net Income 901 1,640 360 386

Customize

Clear All
0Selected
Please try another search
AZN Balance Sheet
AZN
Quick Ratio MRQ 0.51
Current Ratio MRQ 0.86
LT Debt to Equity MRQ 64.55%
Total Debt to Equity MRQ 84.06%
Total Assets
Total Liabilities
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Assets 96,483 94,185 96,579 100,273
Total Liabilities 59,425 59,031 60,628 63,914
Total Equity 37,058 35,154 35,951 36,359

Customize

Clear All
0Selected
Please try another search
AZN Cash Flow Statement
AZN
Cash Flow/Share TTM 6.33
Revenue/Share TTM 28.62
Operating Cash Flow 9.12%
Cash
Net Change in Cash
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Cash From Operating Activities 2,398 2,930 1,248 3,232
Cash From Investing Activities -249 -1,743 -800 -168
Cash From Financing Activities -358 -1,430 -1,295 -3,740
Net Change in Cash 1,797 -294 -873 -685

Customize

Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.